Brief: Simulations Plus Inc - U.S. FDA Renews Annual DILIsym Software Licenses For 2022
May 5 (Reuters) - Simulations Plus Inc SLP.O :
* SIMULATIONS PLUS INC - U.S. FDA RENEWS ANNUAL DILISYM
SOFTWARE
LICENSES FOR 2022
Source text for Eikon: ID:nBw8rBZVva
Further company coverage: SLP.O